Okay, let's tackle this question. The patient is a 75-year-old male with Parkinson's disease who started new medications and now has gambling and inappropriate sexual comments. The wife is concerned about these behaviors.

First, I need to recall the medications used for Parkinson's. The main ones are dopamine agonists, levodopa, MAO-B inhibitors, COMT inhibitors, and maybe anticholinergics. The question is about a new medication causing impulse control disorders like gambling or hypersexuality. Dopamine agonists are known for causing such side effects. For example, pramipexole and ropinirole are associated with impulse control issues. These drugs increase dopamine activity, which can lead to disinhibition.

The other options might include levodopa, which is the gold standard but more commonly causes dyskinesias or hallucinations, not impulsivity. MAO-B inhibitors like selegiline or rasagiline can cause insomnia or orthostatic hypotension, but not these behaviors. Anticholinergics like benztropine might cause confusion or hallucinations, but again, not the specific impulsivity issues mentioned.

So the likely culprit here is a dopamine agonist. The key clinical pearl is that dopamine agonists can lead to impulse control disorders, and students should remember that these are potential side effects, especially in patients who start new medications.

**Core Concept**
Impulse control disorders (e.g., pathological gambling, hypersexuality) are well-documented side effects of **dopamine agonists** in Parkinson’s disease. These medications increase central dopamine activity, which can dysregulate reward pathways in the brain.

**Why the Correct Answer is Right**
**Pramipexole and ropinirole**, dopamine agonists, are classically associated with impulse control disorders. They act on dopamine D2/D3 receptors, which modulate the mesolimbic pathway. Overstimulation of this pathway—responsible for reward and motivation—leads to disinhibited behaviors like gambling, compulsive shopping, or hypersexuality. These effects are more common in patients with preexisting personality traits or subcortical lesions.

**Why Each Wrong Option is Incorrect**
**Option A:** Levodopa (L-DOPA) is the cornerstone of Parkinson’s therapy but typically causes dyskinesias, hallucinations, or on-off phenomena, not impulsivity.
**Option B:** MAO-B inhibitors (e.g., selegiline) may cause insomnia or orthostatic hypotension but not behavioral disinhibition.
**Option C:** Anticholinergics (e.g., benztropine) are used for tremor and rigidity but are more likely to cause confusion or hallucinations, not gambling.

**Clinical Pearl / High-Yield Fact**
**Dopamine agonists** are red flags for exam questions about impulse control disorders in Parkinson’s. Remember the mnemonic: **"DRUGS"**—Dopamine Receptor stimulation = Uncontrolled Gambling, Spending, Sex.

**Correct Answer: C. Pramipexole**

✓ Correct Answer: B. Ropinirole